STEPHEN WEINROTH: Open Payments
NPI 1033130430 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,255 in 131 payments from 15 companies in 2025. Trend: 2023 $33,382 · 2024 $25,240 · 2025 $28,255
Speaker / faculty: $22,560Food & beverage: $2,939Travel & lodging: $2,665Education: $91
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 46 | $22,224 |
| Melinta Therapeutics, LLC | 15 | $4,451 |
| Shionogi Inc | 17 | $290 |
| ViiV Healthcare Company | 12 | $280 |
| Merck Sharp & Dohme LLC | 7 | $183 |
| Insmed, Inc. | 6 | $148 |
| ABBVIE INC. | 10 | $138 |
| La Jolla Pharmaceutical Company | 5 | $128 |
| EVOKE PHARMA, INC. | 1 | $125 |
| PFIZER INC. | 5 | $122 |
Products named: Biktarvy, Rezzayo, Fetroja, DOVATO, Arikayce, GIMOTI, PREVYMIS, XACDURO.
Industry payments across VA — which companies pay providers there.
